HG Vora Capital Management, LLC 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 5:21 pm Sale | 2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | HG Vora Capital Management, LLC | 1,321 2.100% | -660 (-33.31%) | Filing |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | HG Vora Capital Management, LLC | 1,981 24.600% | 1,981 (New Position) | Filing |